SLC5A4 Blocking Peptide (C-Term) Synthetic Peptide Catalog # Bp21548b

SLC5A4 Blocking Peptide (C-Term) Synthetic Peptide Catalog # Bp21548b

10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 SLC5A4 Blocking Peptide (C-term) Synthetic peptide Catalog # BP21548b Specification SLC5A4 Blocking Peptide (C-term) - SLC5A4 Blocking Peptide (C-term) - Product Background Information Sodium-dependent glucose transporter. Primary Accession Q9NY91 SLC5A4 Blocking Peptide (C-term) - References SLC5A4 Blocking Peptide (C-term) - Additional Information Gorboulev V.,et al.Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases. Gene ID 6527 Dunham I.,et al.Nature 402:489-495(1999). Poppe R.,et al.Submitted (DEC-1995) to the Other Names EMBL/GenBank/DDBJ databases. Low affinity sodium-glucose cotransporter, Sodium/glucose cotransporter 3, Na(+)/glucose cotransporter 3, Solute carrier family 5 member 4, SLC5A4, SAAT1, SGLT2 Target/Specificity The synthetic peptide sequence is selected from aa 621-635 of HUMAN SLC5A4 Format Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. Precautions This product is for research use only. Not for use in diagnostic or therapeutic procedures. SLC5A4 Blocking Peptide (C-term) - Protein Information Name SLC5A4 {ECO:0000303|PubMed:13130073} Function Has electrogenic activity in response to glucose, and may function as a glucose Page 1/2 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 sensor (PubMed:<a href="http://www.unipr ot.org/citations/13130073" target="_blank">13130073</a>, PubMed:<a href="http://www.uniprot.org/ci tations/17110502" target="_blank">17110502</a>, PubMed:<a href="http://www.uniprot.org/ci tations/20421923" target="_blank">20421923</a>, PubMed:<a href="http://www.uniprot.org/ci tations/22766068" target="_blank">22766068</a>). Mediates influx of sodium ions into the cell but does not transport sugars (PubMed:<a href="htt p://www.uniprot.org/citations/13130073" target="_blank">13130073</a>, PubMed:<a href="http://www.uniprot.org/ci tations/22766068" target="_blank">22766068</a>). Also potently activated by imino sugars such as deoxynojirimycin (DNJ) (PubMed:<a href="h ttp://www.uniprot.org/citations/17110502" target="_blank">17110502</a>, PubMed:<a href="http://www.uniprot.org/ci tations/20421923" target="_blank">20421923</a>, PubMed:<a href="http://www.uniprot.org/ci tations/22766068" target="_blank">22766068</a>). Cellular Location Cell membrane; Multi-pass membrane protein Tissue Location Expressed in skeletal muscle, where it may localize to the neuromuscular junction (at protein level) (PubMed:13130073) Expressed in small intestine where it may localize to cholinergic neurons of the submucosal plexus and myenteric plexus (at protein level) (PubMed:13130073). Detected in kidney (at protein level) (PubMed:22766068). SLC5A4 Blocking Peptide (C-term) - Protocols Provided below are standard protocols that you may find useful for product applications. • Blocking Peptides Page 2/2 Powered by TCPDF (www.tcpdf.org).

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us